Alisertib in Treating Patients With Myelofibrosis or Relapsed or Refractory Acute Megakaryoblastic Leukemia
Clinical trial NCT02530619 · UNKNOWN
Trial details
- NCT number
- NCT02530619
- Sponsor
- Northwestern University
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-09
- Primary completion
- 2018-05-21
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.